I you look at when wallst buys into bio/pharma tech, you will realize its early in the game for them to consider FUSE as a long term viable investment in that front.
The consumer products are a different animal and until that gets going there won't be a pps increase there either.
So bottom line, FUSE needs to keep pressing forward and continue to prove that they are doing what they said they would.